AGIO

$0.00

(

0.00%

)
Quote details

stock

Agios Pharm

NASDAQ | AGIO

28.09

USD

$0.00

(

0.00%

)

At Close (As of Nov 26, 2025)

$1.54B

Market Cap

-

P/E Ratio

-7.01

EPS

$62.45

52 Week High

$22.24

52 Week Low

HEALTHCARE

Sector

AGIO Chart

Recent Chart
Price Action

AGIO Technicals

Tags:

AGIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

Revenue & Profitability

Earnings Performance

AGIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.7B
Total Current Assets $966M
Cash And Cash Equivalents At Carrying Value $76M
Cash And Short Term Investments $76M
Inventory $28M
Current Net Receivables $4.1M
Total Non Current Assets $698M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $638M
Short Term Investments $817M
Other Current Assets $40M
Other Non Current Assets -
Total Liabilities $122M
Total Current Liabilities $81M
Current Accounts Payable $17M
Deferred Revenue -
Current Debt -
Short Term Debt $17M
Total Non Current Liabilities $41M
Capital Lease Obligations $57M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $57M
Other Current Liabilities $47M
Other Non Current Liabilities $880K
Total Shareholder Equity $1.5B
Treasury Stock -
Retained Earnings -$149M
Common Stock $73K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$390M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.7M
Capital Expenditures $1.7M
Change In Receivables -
Change In Inventory -$8.5M
Profit Loss -
Cashflow From Investment $363M
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $674M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

AGIO News

AGIO Profile

Agios Pharm Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Agios Pharmaceuticals, Inc. is a prominent biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing transformative therapies targeting diseases related to cellular metabolism. With a strong focus on oncology and rare genetic disorders, Agios utilizes its extensive knowledge of metabolic pathways to create innovative treatments that exemplify precision medicine. The company boasts a promising pipeline and actively engages in strategic collaborations to enhance research and development efforts, demonstrating its commitment to advancing scientific understanding and significantly improving patient outcomes through state-of-the-art therapeutic solutions.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
AMBR
+71.20%
$2.70
AXDX
-61.36%
$0.03
INHD
-1.74%
$0.26
PMCB
+36.92%
$0.89
BYND
-0.62%
$0.85
ADAP
-15.14%
$0.05
BITF
-0.71%
$2.77
BMNR
-7.04%
$28.91
T
+0.93%
$25.86
NVDA
+0.86%
$179.35
BTBT
-1.31%
$2.26
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SPRC
+29.92%
$3.17
RIG
+0.74%
$4.05
SRM
+53.27%
$10.30
AUTL
+12.09%
$1.39
BMNU
-13.72%
$6.35
NVO
+4.64%
$47.06
PW
+29.38%
$1.07
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.82%
$12.19
KTTA
+150.06%
$1.21
AFMD
-34.94%
$0.18
RUBI
-9.80%
$0.21
TWOH
0.00%
$0.00
HPE
+1.28%
$21.36
AEHL
+1.87%
$3.26
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CGC
+4.38%
$1.19
MU
+0.26%
$224.53
MNDR
+34.47%
$2.55
PLTZ
-1.80%
$7.63
BBWI
+8.61%
$16.90
LEN
+6.60%
$131.08
NBIS
-3.28%
$88.88
SOFI
+0.90%
$28.58
SAND
-6.04%
$12.12
KEY
+2.68%
$18.37
SHOT
-74.37%
$0.39
OSCR
+1.45%
$16.73
KDLY
+4.61%
$0.46
ZAPP
-46.30%
$0.15
KALA
+15.25%
$0.73
CLSK
+5.92%
$12.52
SLB
+0.53%
$35.90
ONDS
-6.81%
$7.86
CIFR
+6.33%
$18.63
LUMN
+3.76%
$8.00
TSLA
-0.50%
$417.27
KHC
+0.83%
$25.44
CRCL
-3.61%
$70.11
VIVK
-3.90%
$0.13
EXK
+2.09%
$7.81
JOBY
+0.36%
$13.94
IVP
-17.05%
$0.14
GOOGL
-0.33%
$322.36
NFE
-7.43%
$1.12
NIO
+1.15%
$5.56
FLNC
+6.13%
$16.77
AMD
+1.73%
$209.71
LAES
+3.37%
$4.29
PBR
-1.01%
$12.62
MRVL
-0.42%
$83.43
NKE
+2.82%
$63.68
CVX
-0.81%
$148.53
JD
+0.27%
$29.14
RKLB
+0.35%
$42.60
ICU
+4.52%
$0.33
CCCS
+1.68%
$7.25
HAL
+0.07%
$25.69
VINE
+19.12%
$0.35
AMZE
+19.12%
$0.35
VSA
-13.27%
$0.12
YGMZ
-22.75%
$0.14
CX
+3.47%
$10.42
HOOD
+7.11%
$123.78
BB
-3.61%
$4.00
CHWY
+3.16%
$33.54
GOOG
-1.44%
$318.96
MDT
+2.08%
$105.35
DVLT
-6.10%
$2.07
UAA
+2.27%
$4.50
SBUX
+3.08%
$85.91
INTC
+2.60%
$36.76
MDLZ
+0.60%
$56.53
FUBO
+0.32%
$3.11
PTON
+2.12%
$6.74
NTNX
+0.77%
$58.77
JPM
+1.67%
$303.00
LDI
+8.66%
$3.01
SHOP
+1.32%
$157.37
COIN
-0.72%
$254.12
BSFC
+5.26%
$0.00
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
AMBR
+71.20%
$2.70
AXDX
-61.36%
$0.03
INHD
-1.74%
$0.26
PMCB
+36.92%
$0.89
BYND
-0.62%
$0.85
ADAP
-15.14%
$0.05
BITF
-0.71%
$2.77
BMNR
-7.04%
$28.91
T
+0.93%
$25.86
NVDA
+0.86%
$179.35
BTBT
-1.31%
$2.26
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SPRC
+29.92%
$3.17
RIG
+0.74%
$4.05
SRM
+53.27%
$10.30
AUTL
+12.09%
$1.39
BMNU
-13.72%
$6.35
NVO
+4.64%
$47.06
PW
+29.38%
$1.07
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.82%
$12.19
KTTA
+150.06%
$1.21
AFMD
-34.94%
$0.18
RUBI
-9.80%
$0.21
TWOH
0.00%
$0.00
HPE
+1.28%
$21.36
AEHL
+1.87%
$3.26
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CGC
+4.38%
$1.19
MU
+0.26%
$224.53
MNDR
+34.47%
$2.55
PLTZ
-1.80%
$7.63
BBWI
+8.61%
$16.90
LEN
+6.60%
$131.08
NBIS
-3.28%
$88.88
SOFI
+0.90%
$28.58
SAND
-6.04%
$12.12
KEY
+2.68%
$18.37
SHOT
-74.37%
$0.39
OSCR
+1.45%
$16.73
KDLY
+4.61%
$0.46
ZAPP
-46.30%
$0.15
KALA
+15.25%
$0.73
CLSK
+5.92%
$12.52
SLB
+0.53%
$35.90
ONDS
-6.81%
$7.86
CIFR
+6.33%
$18.63
LUMN
+3.76%
$8.00
TSLA
-0.50%
$417.27
KHC
+0.83%
$25.44
CRCL
-3.61%
$70.11
VIVK
-3.90%
$0.13
EXK
+2.09%
$7.81
JOBY
+0.36%
$13.94
IVP
-17.05%
$0.14
GOOGL
-0.33%
$322.36
NFE
-7.43%
$1.12
NIO
+1.15%
$5.56
FLNC
+6.13%
$16.77
AMD
+1.73%
$209.71
LAES
+3.37%
$4.29
PBR
-1.01%
$12.62
MRVL
-0.42%
$83.43
NKE
+2.82%
$63.68
CVX
-0.81%
$148.53
JD
+0.27%
$29.14
RKLB
+0.35%
$42.60
ICU
+4.52%
$0.33
CCCS
+1.68%
$7.25
HAL
+0.07%
$25.69
VINE
+19.12%
$0.35
AMZE
+19.12%
$0.35
VSA
-13.27%
$0.12
YGMZ
-22.75%
$0.14
CX
+3.47%
$10.42
HOOD
+7.11%
$123.78
BB
-3.61%
$4.00
CHWY
+3.16%
$33.54
GOOG
-1.44%
$318.96
MDT
+2.08%
$105.35
DVLT
-6.10%
$2.07
UAA
+2.27%
$4.50
SBUX
+3.08%
$85.91
INTC
+2.60%
$36.76
MDLZ
+0.60%
$56.53
FUBO
+0.32%
$3.11
PTON
+2.12%
$6.74
NTNX
+0.77%
$58.77
JPM
+1.67%
$303.00
LDI
+8.66%
$3.01
SHOP
+1.32%
$157.37
COIN
-0.72%
$254.12
BSFC
+5.26%
$0.00

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.